Molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-positive Klebsiella pneumoniae from bloodstream infections and risk factors for mortality

Journal of Infection and Chemotherapy

Volumn 20, Issue 12, 2014, Pages 817-819

  Gürntke, Stephan ^a   Kohler, Christian ^b   Steinmetz, Ivo ^b   Pfeifer, Yvonne ^c   Eller, Christoph ^c   Gastmeier, Petra ^a   Schwab, Frank ^a   Leistner, Rasmus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Bloodstream infection; ESBL; Klebsiella pneumoniae; Molecular epidemiology

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 3; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; UNCLASSIFIED DRUG; BETA LACTAMASE;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BLOODSTREAM INFECTION; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; KIDNEY DISEASE; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; RISK FACTOR; BACTEREMIA; BIOSYNTHESIS; DRUG EFFECTS; ENZYMOLOGY; GENETICS; GERMANY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

AGED; BACTEREMIA; BETA-LACTAMASES; FEMALE; GENOTYPE; GERMANY; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84940101971     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.08.012     Document Type: Article

References (14)

1. Valenza G, Nickel S, Pfeifer Y, Eller C, Krupa E, Lehner-Reindl V, et al. Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli as intestinal colonizers in the German community. Antimicrobial Agents Chemother 2013:1228-30.
2. Khan E, Schneiders T, Zafar A, Aziz E, Parekh A, Hasan R. Emergence of CTX-M Group 1-ESBL producing Klebsiella pneumoniae from a tertiary care centre in Karachi, Pakistan. J Infect Dev Ctries 2010;4:472-6.
3. Mshana SE, Hain T, Domann E, Lyamuya EF, Chakraborty T, Imirzalioglu C. Predominance of Klebsiella pneumoniae ST14 carrying CTX-M-15 causing neonatal sepsis in Tanzania. BMC Infect Dis 2013;13:466.
4. Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F, et al. Bloodstream infections caused by extended-spectrum-beta-lactamaseproducing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrobial Agents Chemother 2006;50:498-504.
5. Chong Y, Yakushiji H, Ito Y, Kamimura T. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis 2011;30:83-7.
6. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007;60:913-20.
7. Lin YT, Liu CJ, Fung CP, Tzeng CH. Nosocomial Klebsiella pneumoniae bacteraemia in adult cancer patientsecharacteristics of neutropenic and nonneutropenic patients. Scand J Infect Dis 2011;43:603-8.
8. Nasa P, Juneja D, Singh O, Dang R, Singh A. An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome. Eur J Intern Med 2012;23: 192-5.
9. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012;18:54-60.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
11. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011;11:83.
12. Clinical and Laboratorical Standards Institute. Performance standards for antimicrobial susceptibility testing. Wayne, PA, USA: Clinical and Laboratorical Standards Institute (CLSI); 2012. p. 1-184.
13. Grobner S, Linke D, Schutz W, Fladerer C, Madlung J, Autenrieth IB, et al. Emergence of carbapenem-non-susceptible extended-spectrum betalactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol 2009;58:912-22.
14. Carrer A, Nordmann P. CTX-M-15-producing Klebsiella pneumoniae: a change in the epidemiology of ESBL. Pathol Biol (Paris) 2011;59:e133-5.